Quantinuum (NASDAQ:QNT – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Rosenblatt Securities in a note issued to investors on Thursday, Benzinga reports. They currently have a $155.00 price target on the stock. Rosenblatt Securities‘s target price indicates a potential upside of 331.75% from the company’s current price.
Several other research analysts also recently commented on the stock. Sanford C. Bernstein reissued a “hold” rating on shares of Quantinuum in a report on Wednesday, August 12th. Evercore assumed coverage on Quantinuum in a research report on Monday, June 29th. They issued an “outperform” rating and a $98.00 target price on the stock. JPMorgan Chase & Co. initiated coverage on Quantinuum in a research note on Monday, June 29th. They set an “overweight” rating and a $97.00 price target for the company. Yorkville Ives assumed coverage on Quantinuum in a report on Monday, October 5th. They set an “outperform” rating and a $60.00 price target for the company. Finally, Morgan Stanley upgraded shares of Quantinuum from an “equal weight” rating to an “overweight” rating and reduced their price target for the stock from $78.00 to $62.00 in a research report on Thursday, October 15th. Thirteen analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $94.23.
Read Our Latest Research Report on Quantinuum
Quantinuum Stock Performance
Shares of QNT traded down $2.75 during trading hours on Thursday, reaching $35.90. 2,310,873 shares of the stock traded hands, compared to its average volume of 2,327,800. The company has a market capitalization of $9.45 billion and a P/E ratio of -128.21. The company’s 50-day simple moving average is $48.05. Quantinuum has a 52-week low of $33.02 and a 52-week high of $86.79.
Quantinuum (NASDAQ:QNT – Get Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The business had revenue of $8.00 million during the quarter. Equities research analysts expect that Quantinuum will post -4.76 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the business. SBI Securities Co. Ltd. raised its holdings in shares of Quantinuum by 52.8% in the third quarter. SBI Securities Co. Ltd. now owns 6,778 shares of the company’s stock worth $326,000 after buying an additional 2,343 shares during the period. IFP Advisors Inc lifted its stake in shares of Quantinuum by 1,150.0% during the 3rd quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock worth $60,000 after acquiring an additional 1,150 shares during the last quarter. Counterpoint Mutual Funds LLC purchased a new position in Quantinuum during the 3rd quarter valued at $408,000. Vontobel Holding Ltd. bought a new position in Quantinuum in the 3rd quarter valued at $743,000. Finally, Parisi Gray Wealth Management grew its position in Quantinuum by 508.7% in the 3rd quarter. Parisi Gray Wealth Management now owns 18,717 shares of the company’s stock valued at $900,000 after acquiring an additional 15,642 shares during the last quarter.
Quantinuum Company Profile
Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.
Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.
See Also
- Five stocks we like better than Quantinuum
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
